William Lay
Optometrist · Westerville, OHNPI 1902922560
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,044 of the $9,325 with a category attached, or 86.3%. 15 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 27.0% of the total. Among optometrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $78.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$3K
- Alcon$2K
- Visioneering Technologies, Inc.$1K
- Biotissue Holdings Inc.$928
- Sun Pharmaceutical Industries Inc.$501
- Bausch & Lomb Americas Inc.$423
- plus $2K from 9 others
Across 76 payments — averaging $11,604 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson Vision Care, Inc.$606K
- Plexus Optix, Inc.$276K
What the payments were for
- Consulting fees$1,27514%
- Travel & lodging$60%
- Food & beverage$8,04486%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 33 | $2,513 |
| Alcon | 20 | $1,799 |
| Visioneering Technologies, Inc. | 2 | $1,308 |
| Biotissue Holdings Inc. | 14 | $928 |
| Sun Pharmaceutical Industries Inc. | 7 | $501 |
| Bausch & Lomb Americas Inc. | 5 | $423 |
| Oyster Point Pharma, Inc. | 6 | $309 |
| AbbVie(2 entities) | 6 | $306 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $261 |
| Novartis | 7 | $250 |
| Lombart Brothers, Inc. | 6 | $184 |
| Dompe US, Inc. | 2 | $147 |
| Coopervision Inc. | 2 | $138 |
| Tarsus Pharmaceuticals, Inc. | 4 | $129 |
| Kala Pharmaceuticals, Inc. | 2 | $128 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$623
- Precision 1$534
- TOTAL30$441
- BIOTRUE ONE DAY$370
- CEQUA$344
- ILUX$334
- INFUSE$250
- XIIDRA$234
- Prokera$228
- AmnioGraft$228
- TYRVAYA$152
- DAILIES TOTAL1$146
- VUITY$125
- MIEBO$125
- Oxervate$124
- EYSUVIS$122
- RESTASIS MULTIDOSE$113
- AmnioGuard$104
How this compares
$9,325 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 16 | $17,368 |
| XiidraLifitegrast | 17 | $11,510 |
| LumiganBimatoprost | 27 | $11,155 |
| Brimonidine Tartrate | 49 | $4,215 |
| Latanoprost | 133 | $943 |
| Timolol Maleate | 134 | $741 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 35 | $631 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $306 | $28,52343 claims |
| Bausch & Lomb Americas Inc.Xiidra | $423 | $11,51017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,995 optometrist providers in Ohio.
Other optometrist in Westerville
- Bradley JohnsonWesterville$19K
- Mile BrujicBowling Green$1.3M
- Gregory DenaeyerColumbus$846K
- Cory LappinMontgomery$367K
- Chris SmileyColumbus$305K
- Thomas ChesterCleveland$300K
- Carly RoseCincinnati$203K
- Wendy HallierReynoldsburg$200K
- John LahrCincinnati$145K
- Erin RueffColumbus$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.